HYPOSENS

Development of a non-invasive hypoglycaemia sensor for diabetes patients

 Coordinatore ALB. VAN GOOL R&D 

 Organization address address: TUBANTIASTRAAT 43A
city: ENSCHEDE
postcode: 7521 BL

contact info
Titolo: Mr.
Nome: Albert
Cognome: Van Gool
Email: send email
Telefono: -4328072
Fax: -4327721

 Nazionalità Coordinatore Netherlands [NL]
 Totale costo 713˙800 €
 EC contributo 498˙550 €
 Programma FP7-SME
Specific Programme "Capacities": Research for the benefit of SMEs
 Code Call FP7-SME-2007-1
 Funding Scheme BSG-SME
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-11-01   -   2010-10-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ALB. VAN GOOL R&D

 Organization address address: TUBANTIASTRAAT 43A
city: ENSCHEDE
postcode: 7521 BL

contact info
Titolo: Mr.
Nome: Albert
Cognome: Van Gool
Email: send email
Telefono: -4328072
Fax: -4327721

NL (ENSCHEDE) coordinator 0.00
2    Bridges Organisatie-Advies

 Organization address address: Boortorenweg 20
city: Hengelo
postcode: 7550 AN

contact info
Titolo: Mr.
Nome: Andries G.
Cognome: Melchers
Email: send email
Telefono: +31 74 244 3176
Fax: +31 74 244 3174

NL (Hengelo) participant 0.00
3    JUKE SYSTEMTECHNIK GMBH

 Organization address address: TRUMPENSTIEGE 2
city: ALTENBERGE
postcode: 48341

contact info
Titolo: Mr.
Nome: Heinz
Cognome: Juergens
Email: send email
Telefono: -3326
Fax: -6128

DE (ALTENBERGE) participant 0.00
4    LIONIX BV

 Organization address address: HENGELOSESTRAAT 500
city: ENSCHEDE
postcode: 7521 AN

contact info
Titolo: Mr.
Nome: Hans
Cognome: Van Den Vlekkert
Email: send email
Telefono: +31 53 489 3827
Fax: +31 53 489 3601

NL (ENSCHEDE) participant 0.00
5    MEMBRAAN APPLICATIE CENTRUM TWENTE BV

 Organization address address: GAFFELHOEK 19
city: ENSCHEDE
postcode: 7546 MT

contact info
Titolo: Dr.
Nome: Antonius
Cognome: Franken
Email: send email
Telefono: -4777012

NL (ENSCHEDE) participant 0.00
6    Profil Institut fur Stoffwechselforschung GmbH

 Organization address address: Hellersbergstrasse 9
city: Neuss
postcode: 41460

contact info
Titolo: Dr.
Nome: Tim
Cognome: Heise
Email: send email
Telefono: +49 2131 4018-0
Fax: +49 2131 4018-500

DE (Neuss) participant 0.00
7    SOLIANIS MONITORING AG

 Organization address address: LEUTSCHENBACHSTRASSE 46
city: ZURICH
postcode: 8001

contact info
Titolo: Mr.
Nome: Mario
Cognome: Stark
Email: send email
Telefono: +41 44 306 80 40
Fax: +41 44 306 80 41

CH (ZURICH) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

diabetes    finger    patient    blood    status    small    monitoring    amount    stick    hypoglycaemia    values    measuring    components    acetone    tests    concentration    performed    skin    risk    glucose   

 Obiettivo del progetto (Objective)

'Blood glucose monitoring is important in the care of diabetes mellitus and is presently accomplished via a “finger-stick” in which a lancet is used to prick the finger and withdraw a small amount of blood for testing. The problem with the existing “finger-stick”-devices is that blood sampling is painful, it increases the risk for infections and the test is discontinuous. A method for measuring the status of a diabetes patient continuously is preferred, especially at night when the risk of undetected hypoglycaemia is present. Systems for continuous (non-invasive) blood glucose monitoring show promising results for measuring high blood glucose values (hyperglycaemia). However, these systems are not reliable when it comes to measuring low blood glucose values (hypoglycaemia). This is due to the fact that a small variation in the blood glucose concentration in the “hypo-region” has a great impact on the status of the patient. In this project volatile components emanated from the skin are used to determine the state of diabetes patient; one of these components is acetone. An apparatus to clinically test the relation between the amount of acetone and the state of hypoglycaemia (and the concentration of blood glucose) has to be developed. Clinical tests (clamp tests) will be performed in an (academic)hospital. Furthermore, research has to be performed into the combination of several techniques (e.g. impedance spectroscopy) with skin gas measurements to obtain an overall picture of the status of a diabetes patient. Measurements of acetone permeation through the skin and the use of membranes to protect the sensor and/or to enhance the signal are needed. Sensors need to be developed to miniaturise the system. The ultimate goal is to develop a sensing system capable of measuring the condition of a diabetes patient satisfactory and in addition is able to steer the function of, among others an insulin pump.'

Altri progetti dello stesso programma (FP7-SME)

ETOILE (2008)

BIOETHANOL PRODUCTION VIA LIGNOCELLULOSIC FERMENTATION OF OLIVE OIL RESIDUES

Read More  

GREENAVOID (2012)

GREENHOUSE SOLUTION TO AVOID FILM COVER U.V. AND SULPHUR DEGRADATION

Read More  

NANODIGREE (2013)

"Low-cost, Green, Large Scale Manufacturing of new age conducting nanowires displays"

Read More